These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 11791171

  • 1. Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line.
    Wu GS, Ding Z.
    Oncogene; 2002 Jan 03; 21(1):1-8. PubMed ID: 11791171
    [Abstract] [Full Text] [Related]

  • 2. p53-induced apoptosis in the human T-ALL cell line CCRF-CEM.
    Geley S, Hartmann BL, Hattmannstorfer R, Löffler M, Ausserlechner MJ, Bernhard D, Sgonc R, Strasser-Wozak EM, Ebner M, Auer B, Kofler R.
    Oncogene; 1997 Nov 13; 15(20):2429-37. PubMed ID: 9395239
    [Abstract] [Full Text] [Related]

  • 3. Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53.
    Mathiasen IS, Lademann U, Jäättelä M.
    Cancer Res; 1999 Oct 01; 59(19):4848-56. PubMed ID: 10519395
    [Abstract] [Full Text] [Related]

  • 4. Loss of caspase-8 activation pathway is a possible mechanism for CDDP resistance in human laryngeal squamous cell carcinoma, HEp-2 cells.
    Toyozumi Y, Arima N, Izumaru S, Kato S, Morimatsu M, Nakashima T.
    Int J Oncol; 2004 Sep 01; 25(3):721-8. PubMed ID: 15289875
    [Abstract] [Full Text] [Related]

  • 5. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
    Puca R, Nardinocchi L, Pistritto G, D'Orazi G.
    Gynecol Oncol; 2008 Jun 01; 109(3):403-10. PubMed ID: 18395248
    [Abstract] [Full Text] [Related]

  • 6. Human papillomavirus type 16 E6 and HPV-16 E6/E7 sensitize human keratinocytes to apoptosis induced by chemotherapeutic agents: roles of p53 and caspase activation.
    Liu Y, McKalip A, Herman B.
    J Cell Biochem; 2000 May 01; 78(2):334-49. PubMed ID: 10842327
    [Abstract] [Full Text] [Related]

  • 7. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
    Drew L, Fine RL, Do TN, Douglas GP, Petrylak DP.
    Clin Cancer Res; 2002 Dec 01; 8(12):3922-32. PubMed ID: 12473608
    [Abstract] [Full Text] [Related]

  • 8. A plant lignan, 3'-O-methyl-nordihydroguaiaretic acid, suppresses papillomavirus E6 protein function, stabilizes p53 protein, and induces apoptosis in cervical tumor cells.
    Allen KL, Tschantz DR, Awad KS, Lynch WP, DeLucia AL.
    Mol Carcinog; 2007 Jul 01; 46(7):564-75. PubMed ID: 17393435
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to paclitaxel by inducing G2/M arrest and apoptosis.
    Vikhanskaya F, Vignati S, Beccaglia P, Ottoboni C, Russo P, D'Incalci M, Broggini M.
    Exp Cell Res; 1998 May 25; 241(1):96-101. PubMed ID: 9633517
    [Abstract] [Full Text] [Related]

  • 11. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
    Kolfschoten GM, Hulscher TM, Schrier SM, van Houten VM, Pinedo HM, Boven E.
    Gynecol Oncol; 2002 Mar 25; 84(3):404-12. PubMed ID: 11855878
    [Abstract] [Full Text] [Related]

  • 12. Etoposide (VP-16) sensitizes p53-deficient human non-small cell lung cancer cells to caspase-7-mediated apoptosis.
    Chiu CC, Lin CH, Fang K.
    Apoptosis; 2005 May 25; 10(3):643-50. PubMed ID: 15909125
    [Abstract] [Full Text] [Related]

  • 13. Oncolytic herpes simplex virus-1 lacking ICP34.5 induces p53-independent death and is efficacious against chemotherapy-resistant ovarian cancer.
    Coukos G, Makrigiannakis A, Kang EH, Rubin SC, Albelda SM, Molnar-Kimber KL.
    Clin Cancer Res; 2000 Aug 25; 6(8):3342-53. PubMed ID: 10955822
    [Abstract] [Full Text] [Related]

  • 14. Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivity.
    Wu GS, Saftig P, Peters C, El-Deiry WS.
    Oncogene; 1998 Apr 30; 16(17):2177-83. PubMed ID: 9619826
    [Abstract] [Full Text] [Related]

  • 15. Chemoradiation of cervical cancer cells: targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand.
    Koivusalo R, Krausz E, Ruotsalainen P, Helenius H, Hietanen S.
    Cancer Res; 2002 Dec 15; 62(24):7364-71. PubMed ID: 12499281
    [Abstract] [Full Text] [Related]

  • 16. The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific.
    Kissel CK, Schadendorf D, Röckmann H.
    Melanoma Res; 2006 Dec 15; 16(6):527-35. PubMed ID: 17119454
    [Abstract] [Full Text] [Related]

  • 17. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD, Wu JJ, Gillespie S, Borrow J, Hersey P.
    Clin Cancer Res; 2006 Feb 15; 12(4):1355-64. PubMed ID: 16489094
    [Abstract] [Full Text] [Related]

  • 18. Ionizing radiation but not anticancer drugs causes cell cycle arrest and failure to activate the mitochondrial death pathway in MCF-7 breast carcinoma cells.
    Jänicke RU, Engels IH, Dunkern T, Kaina B, Schulze-Osthoff K, Porter AG.
    Oncogene; 2001 Aug 16; 20(36):5043-53. PubMed ID: 11526489
    [Abstract] [Full Text] [Related]

  • 19. Influence of p53 and caspase 3 activity on cell death and senescence in response to methotrexate in the breast tumor cell.
    Hattangadi DK, DeMasters GA, Walker TD, Jones KR, Di X, Newsham IF, Gewirtz DA.
    Biochem Pharmacol; 2004 Nov 01; 68(9):1699-708. PubMed ID: 15450935
    [Abstract] [Full Text] [Related]

  • 20. A novel isoform of TUCAN is overexpressed in human cancer tissues and suppresses both caspase-8- and caspase-9-mediated apoptosis.
    Yamamoto M, Torigoe T, Kamiguchi K, Hirohashi Y, Nakanishi K, Nabeta C, Asanuma H, Tsuruma T, Sato T, Hata F, Ohmura T, Yamaguchi K, Kurotaki T, Hirata K, Sato N.
    Cancer Res; 2005 Oct 01; 65(19):8706-14. PubMed ID: 16204039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.